UroGen Pharma (URGN) option IV into data
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/18/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Apple’s first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
Tweet
Share
E-mailGet Alerts URGN Hot Sheet
Join SI Premium – FREE
UroGen Pharma (NASDAQ: URGN) 30-day option implied volatility is at 227; compared to its 52-week range of 59 to 228 into reports 82.3% 12-month duration of response data from Phase 3 trial.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Softbank Said To Weigh Buying Largest Us Security Firm Allied - Bloomberg
- Popular stocks with increasing option volume: CRWV INTC PLTR MSTR NBIS SOFI AVGO GME ORCL HOOD SMCI
- FAA to approve Boeing 737 MAX 10 as soon as next week - Reuters
Create E-mail Alert Related Categories
OptionsRelated Entities
Options, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
